Article
Histological grade 2 and non-contrast-enhancing phenotype provide prognostic information complementary to DNA methylation classification in TERTp-mutant molecular glioblastomas.
Acta neuropathologica communications - 4 Mar 2026
Sueyoshi Hiroyuki, Fujimoto Kenji, Fujita Katsumi, Tanaka Kazuhito, Inoue Hirotaka, Yamada Rin, Yamamoto Takahiro, Nakachi Yutaka, Kuroda Jun-Ichiro, Shinojima Naoki, Iwamoto Kazuya, Mikami Yoshiki, Mukasa Akitake
Abstract excerpt
Glioblastoma (GBM), IDH-wildtype, is the most common and aggressive primary brain tumor in adults. According to the 2021 WHO classification, IDH-wildtype diffuse gliomas with a TERT promoter (TERTp) mutation, EGFR amplification, or combined whole-chromosome 7 gain and 10 loss (+ 7/− 10) are designated as GBM, IDH-wildtype, regardless of histological grade, and termed molecular GBM (mol-GBM). Although this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
